Dedifferentiated liposarcoma: systemic therapy options

Z Gahvari, A Parkes - Current treatment options in oncology, 2020 - Springer
Opinion statement Over the last several years, the systemic treatment landscape for
dedifferentiated liposarcoma (DDLPS) has notably expanded. Historically, systemic therapy …

[HTML][HTML] Treatment facility: an important prognostic factor for dedifferentiated liposarcoma survival

JM Gootee, CE Curtin, SJ Aurit, SE Randhawa… - Federal …, 2019 - ncbi.nlm.nih.gov
Abstract A National Cancer Database study of on survival outcomes for patients with
dedifferentiated liposarcomas found that insurance status, median household income, and …